Feeds

Annan lines up against US-inspired human cloning ban

Balance at UN tilts in favour of therapeutic?

  • alert
  • submit to reddit

Boost IT visibility and business value

UN Secretary-General Kofi Annan endorsed therapeutic cloning on Thursday, adding his weight to the UN member countries opposing the US-led campaign to ban all human cloning.

A treaty which would ban the cloning of human being has been in the works since 2001, but arguments over extending this to include therapeutic cloning have stalled it. Therapeutic cloning involves harvesting stem cells (cells that have yet to differentiate into a specific type of cell) from human embryos, for use in research into diseases and injuries, and is supported numerous countries, including the UK.

Therapeutic cloning is legal in the United Kingdom, but "very carefully regulated," as a spokeswoman for the Bioindustry Association (BIA) put it. Kofi Annan's endorsement was described as "very welcome," but she said it was not possible to predict the outcome of the ongoing debate. She added that the UK is against the banning of therapeutic cloning.

The UN currently faces a proposal sponsored by the US, Costa Rica and over 50 other nations banning all human cloning, and this is opposed by proposal endorsing therapeutic cloning from a group consisting of Belgium and 21 other nations.

The issue of a total ban on cloning has become heated in the run-up to the US presidential elections, particularly since the death of Christopher Reeve, who played Superman and advocated therapeutic cloning and stem cell research. His widow, Dana Reeve, on Thursday endorsed John Kerry's campaign for the presidency.

US President George Bush opposes government funding for any research involving the future destruction of human embryos, while John Kerry, the Democratic Party candidate, advocates the pursuit of embryonic stem cell studies.

Bush has restricted the allocation of federal funds to embryonic stem cell batches that existed as of August 2001, but these batches are not appropriate for human therapeutic cloning for several reasons. For the most part they are quite old and so their quality has declined. Some also contain mouse cells as well as human cells.

A date for a vote on the proposed ban has yet to be fixed. ®

Related stories

UN to debate embryo cloning
US science alliance eyes artificial retina
NASA hands out $13.5m for radiation studies
£147.5m boost for British particle accelerators

Gartner critical capabilities for enterprise endpoint backup

More from The Register

next story
LOHAN packs bags for SPACEPORT AMERICA!
Spanish launch goes titsup, we're off to the US of A
Gigantic toothless 'DRAGONS' dominated Earth's early skies
Gummy pterosaurs outlived toothy competitors
'Leccy racer whacks petrols in Oz race
ELMOFO rakes in two wins in sanctioned race
TRANSMUTATION claims US LENR company
Ten points of stuff out of a five pound bag
Boffins ID freakish spine-smothered prehistoric critter: The CLAW gave it away
Bizarre-looking creature actually related to velvet worms
CRR-CRRRK, beep, beep: Mars space truck backs out of slippery sand trap
Curiosity finds new drilling target after course correction
BAT-GOBBLING urban SPIDER QUEENS swell to ENORMOUS SIZE
But they'd lose a deathmatch against the coming Humvee-sized, armoured Arctic ones
Astronomers scramble for obs on new comet
Amateur gets fifth confirmed discovery
prev story

Whitepapers

Implementing global e-invoicing with guaranteed legal certainty
Explaining the role local tax compliance plays in successful supply chain management and e-business and how leading global brands are addressing this.
7 Elements of Radically Simple OS Migration
Avoid the typical headaches of OS migration during your next project by learning about 7 elements of radically simple OS migration.
BYOD's dark side: Data protection
An endpoint data protection solution that adds value to the user and the organization so it can protect itself from data loss as well as leverage corporate data.
Consolidation: The Foundation for IT Business Transformation
In this whitepaper learn how effective consolidation of IT and business resources can enable multiple, meaningful business benefits.
High Performance for All
While HPC is not new, it has traditionally been seen as a specialist area – is it now geared up to meet more mainstream requirements?